PR Newswire·Jul 31, 2026, 10:00 AM ET

Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information

A federal court denied Acadia Healthcare Company's motion to dismiss an amended complaint, allowing a securities class action lawsuit to proceed.
The ruling does not determine the truth of allegations or establish liability but confirms the case is not ended at the initial stage.
The lawsuit alleges Acadia misled investors regarding patient admission, detention practices, patient abuse, and billing for medically unnecessary stays.
Allegations claim the company held vulnerable patients against their will and deceived insurance providers into paying for unnecessary treatments.
Public disclosure of allegations followed a September 1, 2024, New York Times investigation that caused Acadia's stock to fall 4.5% to $78.21.
Acadia's stock fell an additional 6.36% to $63.28 on September 27, 2024, after disclosing government inquiries from the U.S. Attorney's Office and a grand jury.
Investors who purchased Acadia securities during the applicable class period and suffered losses may still have rights to participate in the litigation.
Robbins LLP represents investors on a contingency fee basis with no upfront costs to shareholders.
If the case settles, Acadia will incur expenses including potential payouts to shareholders and legal fees.
Investors can contact Robbins LLP via their website, email, or phone at (800) 350-6003 for more information.